NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $221,901 | -81.4% | 2,446 | -84.4% | 0.00% | -66.7% |
Q3 2022 | $1,190,000 | -10.1% | 15,660 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,324,000 | +4.9% | 15,660 | +8.9% | 0.00% | 0.0% |
Q1 2022 | $1,262,000 | +9.2% | 14,382 | +8.8% | 0.00% | 0.0% |
Q4 2021 | $1,156,000 | -11.5% | 13,214 | -17.2% | 0.00% | -25.0% |
Q3 2021 | $1,306,000 | -10.4% | 15,966 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,457,000 | +6.7% | 15,966 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $1,365,000 | +9.4% | 15,966 | +20.8% | 0.01% | +25.0% |
Q4 2020 | $1,248,000 | +196.4% | 13,214 | +197.5% | 0.00% | +33.3% |
Q4 2019 | $421,000 | +7.1% | 4,442 | -2.9% | 0.00% | -50.0% |
Q4 2018 | $393,000 | -27.1% | 4,577 | -26.8% | 0.01% | -33.3% |
Q3 2018 | $539,000 | +14.0% | 6,256 | 0.0% | 0.01% | -18.2% |
Q2 2018 | $473,000 | +85.5% | 6,256 | +105.8% | 0.01% | +37.5% |
Q4 2017 | $255,000 | -2.3% | 3,040 | 0.0% | 0.01% | -11.1% |
Q3 2017 | $261,000 | -28.9% | 3,040 | -30.9% | 0.01% | -66.7% |
Q2 2017 | $367,000 | – | 4,400 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |